IP Library Granted Patent US 10,477,860
Granted Patent B2
US 10,477,860 · App. 15/976,806 · Granted Nov 19, 2019

High osmolarity antimicrobial composition containing one or more organic solvents

Inventor: Matthew Franco Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A01N25/02A01N31/02A01N33/12A01N37/02A01N37/40A01N41/10A61K8/33A61K8/34A61K8/39A61K8/416A61K8/463A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,477,860
App. No.
15/976,806
Granted
Nov 19, 2019
Kind
B2
Abstract

A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.

Claims (26)

1. An antimicrobial composition adapted for dermal application, said composition comprising (a) a carrier base and (b) a liquid composition exhibiting an effective solute concentration of at least about 0.75 Osm/L and a pH of at least 3, wherein said liquid composition consists of

(1) a solvent component that exhibits a δ p value of no more than 14.4 MPa 1/2 and consists of water, one or more C 1 -C 16 acyclic alcohols and, optionally, glycerol; and

(2) a solute component that comprises cationic surfactant and dissociation products of at least two organic acids.

2. The antimicrobial composition of claim 1 wherein said liquid composition exhibits a pH of from 3.5 to 5.5.

3. The antimicrobial composition of claim 1 wherein said one or more C 1 -C 16 acyclic alcohols comprises 2-propanol.

4. The antimicrobial composition of claim 1 wherein said at least two organic acids comprise one or more monoprotic acids.

5. The antimicrobial composition of claim 4 wherein said at least two organic acids further comprise one or more polyacids.

6. The antimicrobial composition of claim 5 wherein said solute component further comprises dissociation product of a salt of said one or more polyacids.

7. The antimicrobial composition of claim 4 wherein said one or more monoprotic acids comprises or is salicylic acid.

8. The antimicrobial composition of claim 7 wherein said at least two organic acids further comprise one or more polyacids.

9. The antimicrobial composition of claim 8 wherein said one or more polyacids comprises or is citric acid.

10. The antimicrobial composition of claim 9 wherein said solute component further comprises dissociation product of a salt of citric acid.

11. The antimicrobial composition of claim 8 wherein said solute component further comprises dissociation product of a salt of said one or more polyacids.

12. The antimicrobial composition of claim 1 wherein said cationic surfactant is benzalkonium chloride.

13. The antimicrobial composition of claim 12 wherein said benzalkonium chloride is present at up to 0.13 weight percent based on said liquid composition.

14. The antimicrobial composition of claim 1 comprising an oleaginous or absorption carrier base.

15. The antimicrobial composition of claim 1 comprising an emulsion carrier base.

16. A composition adapted for dermal application, said composition comprising:

a) a carrier base and

b) a liquid composition which exhibits an effective solute concentration of at least about 0.65 Osm/L and a pH of from 3.5 to 5.5, wherein said liquid composition consists of

1) a solvent component that exhibits a δ p value of no more than 14.4 MPa 1/2 and consists essentially of water, 2-propanol and, optionally, glycerol; and

2) a solute component that comprises benzalkonium chloride, dissociation products of at least one monoprotic acid and at least one polyacid, and dissociation product of a salt of one of said at least one polyacid.

17. The composition of claim 16 wherein said at least one monoprotic acid comprises or is salicylic acid.

18. The composition of claim 17 wherein said at least one polyacid is citric acid.

19. The composition of claim 16 comprising an oleaginous or absorption carrier base.

20. The composition of claim 16 comprising an emulsion carrier base.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (4)
Continuation 14888437
Provisional Application 61818586 · May 2, 2013
Provisional Application 61873500 · Sep 4, 2013
Related Publication 20180255767A1 · Sep 13, 2018
Cited By (2)
US 12,419,830 US 12,691,085